Antiemetic effect of fosaprepitant on high-dose methotrexate chemotherapy for primary central nervous system lymphoma

• In: Poster presentation
• At: Buenos Aires (Argentina) (2016)
• Type: Poster
• Poster code: POS-HPS-031
• By: HATA, Kozue (Kagoshima University Hospital, Kagoshima, Japan)
• Co-author(s): Kozue Hata:|Yukari Shibata:|Akari Shigemi:|Yoriko Nakame:|Takayuki Takahashi:|Ryuji Ikeda:|Yasuo Takeda:
  
• Abstract:

  Chemotherapy-induced nausea and vomiting (CINV) reduces intensity of treatment and patient’s quality of life. Therefore, the control of CINV is necessary to enable the continuation of treatment. Many guidelines on CINV recommend using Neurokinin 1 (NK-1) receptor antagonist in high emetogenic chemotherapy, but only suggest in the case of

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login